TLR4 and neoplasm: In OS, where the TME is often enriched with immunosuppressive M2-like tumor-associated macrophages (TAM) [17,76], TLR4 activation emerges as a potent stimulus to reprogram these cells toward a pro-inflammatory, anti-tumor M1 phenotype.